0001214659-21-011292.txt : 20211108
0001214659-21-011292.hdr.sgml : 20211108
20211108163531
ACCESSION NUMBER: 0001214659-21-011292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211104
FILED AS OF DATE: 20211108
DATE AS OF CHANGE: 20211108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leproust Emily M.
CENTRAL INDEX KEY: 0001753655
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 211388501
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-54170.xml
PRIMARY DOCUMENT
X0306
4
2021-11-04
0001581280
Twist Bioscience Corp
TWST
0001753655
Leproust Emily M.
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
President & CEO
Common Stock
2021-11-04
4
M
false
8208
8.82
A
177050
D
Common Stock
2021-11-04
4
S
false
8208
138.7716
D
168842
D
Common Stock
2021-11-05
4
M
false
1501
8.82
A
170343
D
Common Stock
2021-11-05
4
S
false
1501
139.3856
D
168842
D
Employee Stock Option (right to buy)
26.66
2028-11-18
Common Stock
0
266539
D
Employee Stock Option (right to buy)
23.33
2029-10-23
Common Stock
0
131290
D
Employee Stock Option (right to buy)
5.95
2025-09-28
Common Stock
0
53293
D
Employee Stock Option (right to buy)
8.82
2021-11-04
4
M
false
8208
0
D
2027-09-28
Common Stock
8208
164014
D
Employee Stock Option (right to buy)
8.82
2021-11-05
4
M
false
1501
0
D
2027-09-28
Common Stock
1501
162513
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 28, 2021.
Represents the weighted average sales price per share. The shares sold at prices ranging from $138.75 to $138.775 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $139.04 to $139.82 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
/s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
2021-11-08